Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: J. Wayne Cowens, Perry Nisen

Premium

NanoString Technologies announced the passing of J. Wayne Cowens, who had served as the firm's chief medical officer since 2011. He was 67 years old.

While NanoString searches for a new chief medical officer, the firm has put together a team to handle medical affairs, as well as support regulatory and product development efforts. As such, "the company does not believe Cowens' death will have any material impact on timing and execution of its ongoing product development initiatives, regulatory submissions, or efforts to gain reimbursement and treatment guideline inclusion for the Prosigna Breast Cancer Assay," NanoString said.

Before coming to NanoString, Cowens held senior positions at Genomic Health, Chiron (now Novartis Vaccines & Diagnostics), and Ribozyme Pharmaceuticals.


Sanford Burnham Medical Research Institute has named Perry Nisen as its CEO and as holder of the Donald Bren Chief Executive Chair. Nisen joins Sanford Burnham from GlaxoSmithKline, where he was senior VP of science and innovation.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.